Reflecting the close association of CDK9 and BRD4 and their interplay in transcriptional regulation, co-targeting CDK9 and BRD4 has been found to elicit synergistic effects in multiple cancer types (Fig. 4). The gene discussed is CDK9; the disease is cancer.